Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by MedicalNewsToday featured an episode of a Peer Exchange published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). Episode 8 of the Peer Exchange, “Considering Cost Effectiveness in Cardiovascular Risk Reduction,” addressed the role of PCSK9 inhibitors as treatments for dyslipidemia now that statin therapies are available.
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More